FDA in­spec­tion of UCB fa­cil­i­ty in Bel­gium finds sev­er­al qual­i­ty is­sues

UCB, a Brus­sels-based bio­phar­ma­ceu­ti­cal com­pa­ny, had sev­er­al is­sues cit­ed by FDA in­spec­tors at a man­u­fac­tur­ing fa­cil­i­ty in Bel­gium, but the com­pa­ny is not pan­ick­ing. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER